2023 ESC Guidelines for the management of acute coronary syndromes Page 1 2023 ESC
Guidelines for the management of acute coronary syndromes Developed by the task force on …

Acute myocardial infarction has traditionally been divided into ST elevation or non-ST
elevation myocardial infarction; however, therapies are similar between the two, and the …

Aim The guideline for coronary artery revascularization replaces the 2011 coronary artery
bypass graft surgery and the 2011 and 2015 percutaneous coronary intervention guidelines …

Surveys and registries are needed to verify that real-life daily practice is in keeping with what
is recommended in the guidelines, thus completing the loop between clinical research …

Background Previous randomised trials of bivalirudin versus heparin in patients with ST-
segment elevation myocardial infarction (STEMI) undergoing primary percutaneous …

Background The comparative efficacy of various anticoagulation strategies has not been
clearly established in patients with acute myocardial infarction who are undergoing …

Background Conflicting evidence exists on the efficacy and safety of bivalirudin
administered as part of percutaneous coronary intervention (PCI) in patients with an acute …

Acute Myocardial Infarction | New England Journal of Medicine Skip to main content The New
England Journal of Medicine homepage Advanced Search SEARCH SPECIALTIES Cardiology …

Importance Acute coronary syndrome (ACS), the acute manifestation of ischemic heart
disease, remains a major cause of morbidity and mortality worldwide and is responsible for …

Rapid reperfusion of the infarct-related artery is the cornerstone of therapy for the
management of acute ST-elevation myocardial infarction (STEMI). Canada's geography …